help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 13, 2007
Endocrinology, doi:10.1210/en.2007-0864
A more recent version of this article appeared on March 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
149/3/1009    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwashima, F.
Right arrow Articles by Hirata, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwashima, F.
Right arrow Articles by Hirata, Y.

Submitted on June 27, 2007
Accepted on November 30, 2007

Aldosterone induces superoxide generation via Rac1 activation in endothelial cells

Fumiko Iwashima, Takanobu Yoshimoto*, Isao Minami, Maya Sakurada, Yuki Hirono, and Yukio Hirata

Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Tokyo 113-8519, Japan

* To whom correspondence should be addressed. E-mail: tyoshimoto.cme{at}tmd.ac.jp.

Currently, aldosterone is believed to be involved in the development of cardiovascular injury as a potential cardiovascular risk hormone. However, its exact cellular mechanism(s) remains obscure. This study was undertaken to examine the effect of aldosterone on superoxide production in cultured rat aortic endothelial cells (RAEC) with possible involvement of the small GTP-binding (G) protein Rac1. The aldosterone levels showed a time-dependant (6–24 h) and dose-dependant (10–8–10–6 M) increase in superoxide generation, whose effect was abolished by mineralocorticoid receptor (MR) antagonist (eplerenone), Src inhibitor (PP2) and NAD(P)H oxidase inhibitor (apocynin). Aldosterone activated NADP(H) oxidase and Rac1, whose effects were abolished by eplerenone. The aldosterone-induced superoxide generation was abolished either by non-selective small G protein inhibitor (Clostridium difficile toxin A) or dominant-negative Rac1. Dominant negative Rac1 also inhibited aldosterone-induced ACE gene expression. Thus, the present study is the first to demonstrate that aldosterone induces superoxide generation via MR-mediated activation of NAD(P)H-oxidase and Rac1 in endothelial cells, thereby contributing to the development of aldosterone-induced vascular injury.


Key words: aldosterone • mineralocorticoid receptor • Rac • NAD(P)H oxidase • endothelial cell • superoxide anion







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society